Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genomic footprints of activated telomere maintenance mechanisms in cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pathway and network analysis of more than 2500 whole cancer genomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Long-term health and socioeconomic consequences of childhood and adolescent-onset of narcolepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The role of sleep in the pathophysiology of nocturnal enuresis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Narcolepsy Type 1 (NT1) is a neurological sleep disorder, characterized by the loss of hypocretin/orexin signaling in the brain. Genetic, epidemiological and experimental data support the hypothesis that NT1 is a T-cell-mediated autoimmune disease targeting the hypocretin producing neurons. While autoreactive CD4+ T cells have been detected in patients, CD8+ T cells have only been examined to a minor extent. Here we detect CD8+ T cells specific toward narcolepsy-relevant peptides presented primarily by NT1-associated HLA types in the blood of 20 patients with NT1 as well as in 52 healthy controls, using peptide-MHC-I multimers labeled with DNA barcodes. In healthy controls carrying the disease-predisposing HLA-DQB1*06:02 allele, the frequency of autoreactive CD8+ T cells was lower as compared with both NT1 patients and HLA-DQB1*06:02-negative healthy individuals. These findings suggest that a certain level of CD8+ T-cell reactivity combined with HLA-DQB1*06:02 expression is important for NT1 development.

OriginalsprogEngelsk
Artikelnummer837
TidsskriftNature Communications
Vol/bind10
Udgave nummer1
Sider (fra-til)837
ISSN2041-1723
DOI
StatusUdgivet - 1 dec. 2019

ID: 58007203